The prevalence rate in New Brunswick clearly exceeds the current national average (7.3%) and the national average forecasted for 2020 (9.9%). "These results should serve as a wake-up call to all in the province that a focused and comprehensive action plan is required to address this burden," added McDougall. "If action is not taken soon, this growing burden will not only continue to afflict the health of thousands more in New Brunswick, but it could also cripple our healthcare system and the future prosperity of the province."

To offset the burden caused by diabetes, the Canadian Diabetes Association has recommended that all governments immediately move to introduce comprehensive diabetes strategies that address the major drivers increasing diabetes costs and prevalence. Targeted investments in improving access to diabetes health services, education, medications, devices and supplies and financial support are all key elements in the prevention of diabetes and the serious medical complications associated with the disease.

The New Brunswick Diabetes Cost Model is based on the Association's Canadian Diabetes Cost Model, An Economic Tsunami: the Cost of Diabetes in Canada, December 2009 report, which was developed with support of Novo Nordisk Canada Inc. The Model uses the most current Canadian data to determine the current and future economic impact and prevalence rates of diabetes.

Source: CANADIAN DIABETES ASSOCIATION